Summary
75 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 42% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 16.3 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 37% a year over 5 years. Over the last 3 years it grew by 46% a year. Earnings per share grew by 42% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.89%
- Paid out of profit
- 14%
- Raised in a row
- 1 year
You receive $0.62 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 7
- Hold 0
- Sell 0
Today's price within the analysts' price targets
The average target of $82.67 is 19% above today's price. 100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
The company reports no revenue by product.
By region
- UNITED STATES 59%
- Rest Of The World 41%
UNITED STATES brings in 59% of revenue.
Segments in detail